Board Changes

Revolution Beauty Group PLC
25 May 2023
 

For Immediate Release

25 May 2023

 

 

 

 

 

 

REVOLUTION BEAUTY GROUP PLC

("Revolution Beauty", the "Group" or the "Company")

 

Board Changes

Revolution Beauty Group plc (AIM: REVB), the multi-channel mass beauty innovator, is pleased to announce the appointment of Derek Zissman as Non-Executive Chairman, replacing Tom Allsworth. Tom Allsworth is resigning as a director of Revolution Beauty with immediate effect, prior to the publication of the Company's FY22 accounts, as previously referenced in the Company's announcement of 13 January 2023. The Company continues to expect to publish its FY22 accounts during May 2023.

Derek was appointed as Senior Non-Executive Director to the Company on its IPO in July 2021, and more recently led the investigation committee in relation to the independent investigation. Derek has led the structural and governance changes which followed the outcome of the independent investigation.

Derek Zissman, Non-Executive Chairman, commented:

"Whilst it's been a difficult number of months for the Group, I am confident that with the new management team and corporate governance structures in place, the mistakes of the past will not be repeated. I'd like to thank Tom Allsworth for his contribution and effort since he co-founded the Company in 2013."

 


For further information please contact:




Revolution Beauty Investor Relations


Bob Holt / Elizabeth Lake

Investor.Relations@revolutionbeautyplc.com


 

Joint Corporate Brokers

 

 

Zeus (NOMAD): Nick Cowles /Jamie Peel /Jordan Warburton

 

Tel: +44 (0) 161 831 1512

Liberum: Clayton Bush / Edward Thomas / Miquela Bezuidenhoudt

 

Tel: +44 (0) 203 100 2222



Media enquiries:


Headland Consultancy

Rosh Field / Will Smith

Tel: +44 (0)20 3805 4822

Revolutionbeauty@headlandconsultancy.com

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings